Immunotherapy with Keytruda (Pembolizumab) in test — Page 2

Hospital de la Familia offers immunotherapy with Keytruda at about $10,000 – typically covering the medication, 1-2 days hospital stay, and medical supervision. Dr. Marco Sariñana brings 18 years of experience of combined plastic and general surgery experience to oversee treatments. The clinic is accredited by Mexico's Consejo de Salubridad General and provides personalized care in a boutique facility just 200 yards from the US border. Media outlets like The New York Times and CNN have featured their transparent pricing model.

Prof. Dr. Kamil Yalçın Polat specializes in surgical treatment of hepatobiliary cancers with advanced training at Memorial Sloan Kettering Cancer Center and over 75 published medical articles. Immunotherapy with Keytruda typically costs around $3,500–$6,600. The hospital holds JCI accreditation for international treatment standards.

Prof. Heuser, Chief Physician at an academic teaching hospital of University of Cologne, specializes in urology and oncology. The comprehensive consultation package may cost around $2,350 – typically including detailed anamnesis, ultrasound examination, blood tests, tumor markers, and tumorboard evaluation. The clinic is certified by German Cancer Society and ranked among top German hospitals by Focus magazine.

Lokman Hekim Istanbul Hospital offers a comprehensive diagnostic package for immunotherapy preparation at around $2,000, covering radiological screenings, biochemistry tests, biopsy, and doctor consultation. The ISO 9001-certified facility includes interpreter services, airport transfers, and private nursing support. With a 4.6/5 rating from patients, the hospital specializes in advanced oncology diagnostics.

Fuda Cancer Hospital offers Immunotherapy with Keytruda (Pembrolizumab) for advanced cancer cases, backed by JCI accreditation. Treatment may cost around $3,200–$7,700. Prof. Niu Lizhi, President of Fuda, has performed over 10,000 minimally invasive procedures and specializes in cutting-edge cancer therapies. The hospital has treated over 30,000 patients from 100+ countries.

Liv Bona Dea Hospital is JCI-accredited and follows the Turkish Liv Hospital brand standards. Immunotherapy with Keytruda may cost around $6,900 for the first course, typically covering the treatment scheme and drugs. Each follow-up course costs approximately $6,500. The clinic provides free interpreter services and transfers. The 37,500 sq.m facility has 156 beds including 28 intensive care units.

Lokman Hekim University Ankara Hospital holds ISO and International Health Tourism Authorization Certificate, ensuring quality standards. The consultation and diagnostic package may cost around 1,760 USD, typically including doctor consultation, laboratory tests, radiological screenings, and PET-CT scan. As a 216-bed multi-specialty facility with 6 operating theaters, the hospital serves international patients from various regions. The initial package prepares patients for immunotherapy treatment planning.

Prof. Cemil Bilir specializes in immunotherapy and molecular oncology with 21 years of experience of clinical experience. Keytruda treatment at VM Medical Park Pendik may cost around $6,500 per cycle, typically covering pre-operative consultation, lab tests, doctor fees, and transfers. The JCI-accredited facility features 10 operating theaters and 400 beds. Prof. Bilir holds memberships with ASCO and ESMO, following international oncology standards.

Hospital Quiron Barcelona specializes in advanced oncology care through the Baselga Institute of Oncology, collaborating with leading American centers. Dr. Jesus Soberino, a key member of the Melanoma Unit at Vall d’Hebron Institute of Oncology, has led trials that led to the approval of Pembrolizumab for metastatic melanoma. Immunotherapy with Keytruda typically costs around $9,600–$18,100. The hospital offers personalized care for international patients, including tailored treatment plans and airport transfers.

Assuta Medical Center provides advanced Immunotherapy with Keytruda (Pembolizumab), led by Dr. Riad Hadad, a specialist in gastrointestinal and liver oncology who trained at the University of Toronto. The treatment may cost around $7,500–$51,500. Dr. Hadad has authored 60+ scientific publications and heads the liver, pancreas, and gallbladder department at Assuta.